 Makoto Miyazaki
Concepts (480)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 37 | 2015 | 57 | 4.880 |
Why?
| | Vascular Calcification | 9 | 2022 | 123 | 4.450 |
Why?
| | Renal Insufficiency, Chronic | 8 | 2022 | 589 | 2.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 195 | 1.940 |
Why?
| | Atherosclerosis | 8 | 2021 | 345 | 1.910 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 18 | 1.860 |
Why?
| | Endoplasmic Reticulum | 5 | 2021 | 241 | 1.820 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 29 | 1.730 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 179 | 1.620 |
Why?
| | Fatty Acids | 18 | 2018 | 407 | 1.390 |
Why?
| | Liver | 20 | 2019 | 1816 | 1.360 |
Why?
| | Autophagy | 4 | 2022 | 315 | 1.340 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 97 | 1.320 |
Why?
| | Calcinosis | 4 | 2014 | 282 | 1.110 |
Why?
| | Lipids | 9 | 2018 | 607 | 1.080 |
Why?
| | Mice | 63 | 2022 | 15520 | 1.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 200 | 1.010 |
Why?
| | Membrane Proteins | 3 | 2022 | 1055 | 1.000 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 20 | 0.870 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 14 | 0.850 |
Why?
| | Leptin | 9 | 2010 | 231 | 0.840 |
Why?
| | Stearic Acids | 2 | 2012 | 14 | 0.840 |
Why?
| | Animals | 71 | 2022 | 33381 | 0.830 |
Why?
| | Mice, Knockout | 25 | 2019 | 2680 | 0.750 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 236 | 0.740 |
Why?
| | Vascular Diseases | 2 | 2014 | 241 | 0.700 |
Why?
| | Starvation | 1 | 2019 | 24 | 0.690 |
Why?
| | Isoenzymes | 6 | 2006 | 297 | 0.680 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.670 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 9 | 0.670 |
Why?
| | Lipid Metabolism | 13 | 2018 | 477 | 0.630 |
Why?
| | Apolipoproteins E | 4 | 2014 | 90 | 0.590 |
Why?
| | Kidney Diseases | 4 | 2019 | 439 | 0.580 |
Why?
| | Coronary Vessels | 2 | 2022 | 233 | 0.580 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 26 | 0.580 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 404 | 0.570 |
Why?
| | Cholesterol | 7 | 2016 | 373 | 0.570 |
Why?
| | Mice, Inbred C57BL | 21 | 2020 | 4908 | 0.560 |
Why?
| | Lipogenesis | 4 | 2012 | 66 | 0.560 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 66 | 0.530 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 647 | 0.530 |
Why?
| | Triglycerides | 10 | 2014 | 519 | 0.470 |
Why?
| | Osteogenesis | 4 | 2021 | 213 | 0.470 |
Why?
| | Metabolomics | 1 | 2018 | 550 | 0.450 |
Why?
| | Blood Vessels | 2 | 2011 | 187 | 0.440 |
Why?
| | Kidney | 7 | 2021 | 1353 | 0.430 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 35 | 0.420 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 4 | 2020 | 34 | 0.410 |
Why?
| | Cisplatin | 3 | 2020 | 271 | 0.400 |
Why?
| | Dietary Fats | 4 | 2007 | 322 | 0.390 |
Why?
| | Fatty Liver | 3 | 2012 | 253 | 0.370 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2445 | 0.370 |
Why?
| | Cells, Cultured | 11 | 2019 | 4077 | 0.370 |
Why?
| | Signal Transduction | 13 | 2022 | 4709 | 0.370 |
Why?
| | Transcription Factors | 5 | 2006 | 1570 | 0.350 |
Why?
| | DNA-Binding Proteins | 6 | 2008 | 1346 | 0.350 |
Why?
| | Inflammation | 6 | 2021 | 2566 | 0.340 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 1798 | 0.330 |
Why?
| | Protein Isoforms | 5 | 2019 | 345 | 0.330 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2025 | 0.330 |
Why?
| | Macrophages | 6 | 2021 | 1324 | 0.320 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1171 | 0.320 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 8 | 2011 | 57 | 0.320 |
Why?
| | Phosphorylation | 8 | 2018 | 1633 | 0.310 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 14 | 0.310 |
Why?
| | Oleic Acid | 4 | 2009 | 34 | 0.310 |
Why?
| | Male | 35 | 2021 | 57801 | 0.310 |
Why?
| | Adiposity | 3 | 2010 | 516 | 0.310 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 174 | 0.310 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 178 | 0.290 |
Why?
| | Myocardium | 4 | 2010 | 970 | 0.280 |
Why?
| | Receptors, LDL | 2 | 2018 | 40 | 0.270 |
Why?
| | Transcription, Genetic | 3 | 2020 | 1323 | 0.270 |
Why?
| | Insulin Resistance | 3 | 2009 | 1180 | 0.270 |
Why?
| | Fatty Acid Desaturases | 1 | 2006 | 34 | 0.270 |
Why?
| | Fructokinases | 2 | 2016 | 63 | 0.260 |
Why?
| | Obesity | 7 | 2010 | 2746 | 0.250 |
Why?
| | Epithelial Cells | 3 | 2019 | 963 | 0.250 |
Why?
| | Energy Metabolism | 3 | 2008 | 767 | 0.250 |
Why?
| | Humans | 33 | 2022 | 118974 | 0.240 |
Why?
| | Diet | 4 | 2021 | 1153 | 0.240 |
Why?
| | Cell Line | 5 | 2018 | 2707 | 0.230 |
Why?
| | Glomerulonephritis | 2 | 2021 | 60 | 0.230 |
Why?
| | Liver X Receptors | 5 | 2012 | 30 | 0.230 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 131 | 0.220 |
Why?
| | Isothiocyanates | 1 | 2022 | 3 | 0.220 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 7 | 0.220 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 290 | 0.210 |
Why?
| | Fructose | 1 | 2004 | 204 | 0.210 |
Why?
| | Lysosomes | 2 | 2021 | 136 | 0.210 |
Why?
| | Adipose Tissue | 3 | 2010 | 606 | 0.210 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 7 | 0.210 |
Why?
| | Acute Kidney Injury | 2 | 2020 | 709 | 0.200 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2016 | 454 | 0.200 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 64 | 0.200 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 99 | 0.200 |
Why?
| | Phosphates | 1 | 2022 | 167 | 0.200 |
Why?
| | Toxins, Biological | 1 | 2020 | 16 | 0.190 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 133 | 0.190 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 130 | 0.190 |
Why?
| | Skin | 1 | 2005 | 657 | 0.190 |
Why?
| | Biomarkers | 4 | 2021 | 3588 | 0.190 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 43 | 0.190 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 175 | 0.190 |
Why?
| | Homeostasis | 2 | 2021 | 594 | 0.190 |
Why?
| | Podocytes | 2 | 2019 | 57 | 0.190 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 9 | 0.190 |
Why?
| | Insulin | 7 | 2009 | 2162 | 0.180 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2071 | 0.180 |
Why?
| | Disease Models, Animal | 10 | 2019 | 3730 | 0.180 |
Why?
| | Tissue Distribution | 3 | 2007 | 334 | 0.180 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 105 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 116 | 0.180 |
Why?
| | Down-Regulation | 4 | 2008 | 627 | 0.180 |
Why?
| | Cattle | 3 | 2011 | 978 | 0.180 |
Why?
| | Hepatocytes | 2 | 2019 | 205 | 0.170 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 369 | 0.170 |
Why?
| | Tretinoin | 1 | 2020 | 116 | 0.170 |
Why?
| | Heat-Shock Response | 1 | 2019 | 59 | 0.170 |
Why?
| | Fatty Acids, Unsaturated | 3 | 2005 | 86 | 0.170 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 46 | 0.170 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 70 | 0.170 |
Why?
| | Intestine, Small | 1 | 2020 | 131 | 0.170 |
Why?
| | Amino Acids | 2 | 2021 | 465 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2021 | 150 | 0.170 |
Why?
| | Receptors, Fc | 1 | 2019 | 48 | 0.170 |
Why?
| | Carrier Proteins | 2 | 2021 | 726 | 0.160 |
Why?
| | Osteopontin | 1 | 2018 | 39 | 0.160 |
Why?
| | Serum Albumin | 1 | 2019 | 146 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 64 | 0.160 |
Why?
| | Fever | 1 | 2019 | 283 | 0.160 |
Why?
| | Disease Progression | 3 | 2021 | 2490 | 0.160 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 136 | 0.160 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 177 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2017 | 39 | 0.150 |
Why?
| | Chelating Agents | 1 | 2017 | 74 | 0.150 |
Why?
| | Adaptive Immunity | 1 | 2018 | 161 | 0.150 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 311 | 0.150 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.150 |
Why?
| | Phosphorus | 1 | 2017 | 84 | 0.150 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 280 | 0.150 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 823 | 0.140 |
Why?
| | Cell Proliferation | 3 | 2020 | 2275 | 0.140 |
Why?
| | Adipocytes, White | 2 | 2022 | 17 | 0.140 |
Why?
| | Mitochondria | 3 | 2019 | 786 | 0.140 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 394 | 0.140 |
Why?
| | Dietary Carbohydrates | 2 | 2007 | 153 | 0.140 |
Why?
| | Heart | 4 | 2010 | 631 | 0.140 |
Why?
| | Muscle, Smooth | 1 | 2016 | 157 | 0.140 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 50 | 0.140 |
Why?
| | Base Sequence | 4 | 2007 | 2159 | 0.140 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 76 | 0.130 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 355 | 0.130 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1597 | 0.130 |
Why?
| | Protein Binding | 3 | 2018 | 1975 | 0.130 |
Why?
| | Cell Differentiation | 3 | 2012 | 1753 | 0.130 |
Why?
| | Albuminuria | 1 | 2016 | 195 | 0.130 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1158 | 0.130 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 198 | 0.130 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2018 | 209 | 0.130 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 565 | 0.130 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 10 | 0.130 |
Why?
| | Tetraspanins | 1 | 2014 | 16 | 0.130 |
Why?
| | Immunoglobulin G | 1 | 2019 | 788 | 0.130 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.130 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 41 | 0.130 |
Why?
| | Bone Marrow | 1 | 2016 | 255 | 0.120 |
Why?
| | Ezetimibe | 1 | 2014 | 23 | 0.120 |
Why?
| | Osteoblasts | 2 | 2012 | 115 | 0.120 |
Why?
| | Azetidines | 1 | 2014 | 29 | 0.120 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 394 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 811 | 0.120 |
Why?
| | Simvastatin | 1 | 2014 | 65 | 0.120 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 548 | 0.120 |
Why?
| | Bone Density | 1 | 2017 | 449 | 0.120 |
Why?
| | HeLa Cells | 4 | 2012 | 583 | 0.120 |
Why?
| | Dehydration | 1 | 2013 | 61 | 0.110 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 702 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1795 | 0.110 |
Why?
| | Muscle, Skeletal | 5 | 2005 | 1515 | 0.110 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 17 | 0.110 |
Why?
| | Benzoates | 1 | 2012 | 40 | 0.110 |
Why?
| | Catechin | 1 | 2012 | 26 | 0.110 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 940 | 0.110 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 82 | 0.110 |
Why?
| | Nicorandil | 1 | 2012 | 16 | 0.110 |
Why?
| | Isoxazoles | 1 | 2012 | 56 | 0.110 |
Why?
| | Body Weight | 6 | 2010 | 934 | 0.110 |
Why?
| | Minerals | 1 | 2012 | 39 | 0.110 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 16 | 0.110 |
Why?
| | Case-Control Studies | 3 | 2017 | 3171 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 612 | 0.100 |
Why?
| | RNA, Messenger | 7 | 2018 | 2657 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 79 | 0.100 |
Why?
| | DNA Primers | 3 | 2007 | 533 | 0.100 |
Why?
| | Female | 17 | 2022 | 61565 | 0.100 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 38 | 0.100 |
Why?
| | Sulfonamides | 2 | 2012 | 445 | 0.100 |
Why?
| | Risk Factors | 3 | 2022 | 9000 | 0.100 |
Why?
| | Aorta | 2 | 2012 | 367 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 965 | 0.100 |
Why?
| | Antioxidants | 2 | 2012 | 564 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 40 | 0.100 |
Why?
| | Molecular Imaging | 1 | 2011 | 54 | 0.100 |
Why?
| | Etoposide | 1 | 2011 | 149 | 0.100 |
Why?
| | Models, Biological | 5 | 2006 | 1715 | 0.100 |
Why?
| | Rats | 4 | 2021 | 5392 | 0.100 |
Why?
| | Glucose | 2 | 2007 | 953 | 0.100 |
Why?
| | Middle Aged | 5 | 2022 | 27617 | 0.100 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 12 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 157 | 0.090 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 198 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2874 | 0.090 |
Why?
| | Hypertriglyceridemia | 2 | 2008 | 39 | 0.090 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 1974 | 0.090 |
Why?
| | Fibroblasts | 1 | 2014 | 842 | 0.090 |
Why?
| | Aging | 2 | 2019 | 1670 | 0.090 |
Why?
| | Mice, Obese | 3 | 2006 | 58 | 0.090 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 4 | 0.090 |
Why?
| | Blotting, Northern | 3 | 2005 | 194 | 0.090 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 3 | 0.090 |
Why?
| | Cholic Acids | 1 | 2008 | 17 | 0.080 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 93 | 0.080 |
Why?
| | Microscopy | 1 | 2010 | 125 | 0.080 |
Why?
| | Ceramides | 2 | 2010 | 104 | 0.080 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 3 | 0.080 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 289 | 0.080 |
Why?
| | Lipocalin-2 | 2 | 2020 | 64 | 0.080 |
Why?
| | Lung Neoplasms | 2 | 2020 | 2220 | 0.080 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 133 | 0.080 |
Why?
| | Transgenes | 2 | 2006 | 174 | 0.080 |
Why?
| | Receptor, Insulin | 2 | 2006 | 100 | 0.080 |
Why?
| | Acyltransferases | 2 | 2005 | 53 | 0.080 |
Why?
| | Tumor Burden | 2 | 2020 | 274 | 0.080 |
Why?
| | Microsomes | 2 | 2007 | 24 | 0.080 |
Why?
| | Glycogen | 2 | 2004 | 59 | 0.080 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.080 |
Why?
| | Gluconeogenesis | 1 | 2007 | 66 | 0.080 |
Why?
| | Time Factors | 4 | 2019 | 6412 | 0.080 |
Why?
| | Histoplasma | 1 | 2007 | 13 | 0.080 |
Why?
| | Histoplasmosis | 1 | 2007 | 15 | 0.080 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 368 | 0.080 |
Why?
| | Sucrose | 1 | 2007 | 104 | 0.080 |
Why?
| | Animal Feed | 2 | 2004 | 55 | 0.080 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 71 | 0.070 |
Why?
| | Pedigree | 1 | 2008 | 485 | 0.070 |
Why?
| | Mutation | 5 | 2018 | 3457 | 0.070 |
Why?
| | Aged | 3 | 2022 | 19657 | 0.070 |
Why?
| | Blood Pressure | 4 | 2016 | 1664 | 0.070 |
Why?
| | Lipolysis | 2 | 2022 | 42 | 0.070 |
Why?
| | Blotting, Western | 5 | 2007 | 1194 | 0.070 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.070 |
Why?
| | Colitis | 1 | 2008 | 219 | 0.070 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2871 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 41 | 0.060 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 522 | 0.060 |
Why?
| | Thermogenesis | 1 | 2004 | 43 | 0.060 |
Why?
| | Lipodystrophy | 1 | 2004 | 18 | 0.060 |
Why?
| | Hypothermia | 1 | 2004 | 32 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 41 | 0.060 |
Why?
| | Up-Regulation | 2 | 2004 | 872 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1636 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2674 | 0.060 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 73 | 0.060 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 49 | 0.060 |
Why?
| | Cold Temperature | 1 | 2004 | 132 | 0.060 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 13 | 0.060 |
Why?
| | Cholestasis | 1 | 2006 | 228 | 0.060 |
Why?
| | Mice, SCID | 1 | 2004 | 333 | 0.060 |
Why?
| | Foam Cells | 2 | 2016 | 15 | 0.060 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 112 | 0.060 |
Why?
| | Animals, Newborn | 1 | 2005 | 806 | 0.060 |
Why?
| | DNA, Complementary | 1 | 2003 | 268 | 0.060 |
Why?
| | Cell Membrane | 2 | 2005 | 710 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 372 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 145 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 4 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 35 | 0.050 |
Why?
| | Carnitine O-Palmitoyltransferase | 3 | 2007 | 47 | 0.050 |
Why?
| | Protein Transport | 2 | 2019 | 412 | 0.050 |
Why?
| | RNA | 2 | 2007 | 833 | 0.050 |
Why?
| | Aminopterin | 1 | 2021 | 2 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 495 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2003 | 219 | 0.050 |
Why?
| | Phospholipids | 1 | 2003 | 208 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 21 | 0.050 |
Why?
| | Apoptosis | 3 | 2020 | 2484 | 0.050 |
Why?
| | Japan | 1 | 2021 | 97 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 46 | 0.050 |
Why?
| | Proteinuria | 1 | 2021 | 99 | 0.050 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 3 | 0.050 |
Why?
| | Folic Acid | 1 | 2021 | 161 | 0.050 |
Why?
| | Biological Assay | 1 | 2021 | 122 | 0.050 |
Why?
| | Methotrexate | 1 | 2021 | 227 | 0.050 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 59 | 0.050 |
Why?
| | Models, Genetic | 1 | 2003 | 595 | 0.050 |
Why?
| | Butadienes | 1 | 2020 | 33 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 814 | 0.050 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 38 | 0.050 |
Why?
| | Vegetables | 1 | 2021 | 133 | 0.050 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 10 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 139 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 854 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 32 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 86 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 576 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 155 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 34 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 74 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 119 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 51 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 483 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 454 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 399 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1388 | 0.040 |
Why?
| | TRPP Cation Channels | 1 | 2018 | 63 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 292 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 40 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 996 | 0.040 |
Why?
| | Weight Loss | 1 | 2002 | 655 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 187 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1094 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 683 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 401 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2011 | 828 | 0.040 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 9 | 0.040 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 156 | 0.040 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 22 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 42 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1178 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 440 | 0.030 |
Why?
| | Gene Silencing | 1 | 2016 | 177 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 128 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 175 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 405 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 273 | 0.030 |
Why?
| | Immunoblotting | 2 | 2005 | 307 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 491 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 493 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2424 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1489 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 29 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 31 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1945 | 0.030 |
Why?
| | Pregnancy | 1 | 2005 | 5691 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 462 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 101 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 663 | 0.030 |
Why?
| | beta Catenin | 1 | 2014 | 219 | 0.030 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 461 | 0.030 |
Why?
| | Macaca fascicularis | 1 | 2012 | 53 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 44 | 0.030 |
Why?
| | Cytochromes c | 1 | 2012 | 64 | 0.030 |
Why?
| | Streptozocin | 1 | 2012 | 23 | 0.030 |
Why?
| | Cholesterol Esters | 1 | 2011 | 9 | 0.030 |
Why?
| | Bone Matrix | 1 | 2011 | 8 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1206 | 0.030 |
Why?
| | Blood Glucose | 3 | 2006 | 1939 | 0.030 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 34 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4552 | 0.030 |
Why?
| | Biological Transport | 1 | 2012 | 382 | 0.030 |
Why?
| | Serum | 1 | 2011 | 63 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 459 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 565 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 361 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 455 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2012 | 247 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 140 | 0.020 |
Why?
| | Uric Acid | 1 | 2013 | 354 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 9 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 211 | 0.020 |
Why?
| | Feces | 1 | 2012 | 396 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 165 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 102 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 96 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 57 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6561 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 173 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 243 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 982 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 11 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 4708 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 13 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 443 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1900 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 19 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 71 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 56 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 125 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 2851 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 433 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 12 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 8 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 26 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 64 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 273 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 69 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 2 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 135 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 23 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2478 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 44 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 510 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 468 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 188 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 27 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 54 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 473 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 82 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2010 | 446 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2008 | 162 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 34 | 0.020 |
Why?
| | Octoxynol | 1 | 2005 | 12 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 171 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 14 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 138 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 55 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 161 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 100 | 0.020 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.020 |
Why?
| | Fish Oils | 1 | 2005 | 25 | 0.020 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.020 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 2 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2005 | 124 | 0.020 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 8 | 0.020 |
Why?
| | Serine | 1 | 2005 | 138 | 0.020 |
Why?
| | Thinness | 1 | 2005 | 91 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 314 | 0.020 |
Why?
| | Sphingomyelins | 1 | 2004 | 29 | 0.020 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 15 | 0.020 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 30 | 0.020 |
Why?
| | Echocardiography | 1 | 2007 | 556 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2004 | 38 | 0.020 |
Why?
| | Catalysis | 1 | 2005 | 295 | 0.020 |
Why?
| | Glycerol | 1 | 2005 | 88 | 0.020 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 3 | 0.020 |
Why?
| | Homozygote | 1 | 2005 | 190 | 0.020 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 16 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 338 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 183 | 0.020 |
Why?
| | Plasmids | 1 | 2005 | 355 | 0.020 |
Why?
| | Cysteine | 1 | 2005 | 184 | 0.020 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 15 | 0.020 |
Why?
| | Fats | 1 | 2004 | 13 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2009 | 732 | 0.020 |
Why?
| | Trans-Activators | 1 | 2006 | 373 | 0.020 |
Why?
| | Adult | 2 | 2021 | 31512 | 0.020 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 192 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 167 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 126 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 412 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 211 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 46 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 38 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 215 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 443 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 447 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1012 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 653 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 888 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 333 | 0.010 |
Why?
| | Lipoproteins, VLDL | 1 | 2002 | 20 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 11 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 33 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2006 | 1085 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 848 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 59 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 138 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 226 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1308 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 816 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 770 | 0.010 |
Why?
| | Eating | 1 | 2002 | 369 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2002 | 586 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2092 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|